Physicians are tested for drugs more often than most people assume, but the requirement rarely comes from a single federal law. It usually comes from three separate sources layered on top of each other: the hospital or group that credentials and employs the physician, the Drug Enforcement Administration's interest in anyone who holds a controlled substance registration, and the state medical board that licenses the physician and may require monitoring through a Physician Health Program. This article walks through where each requirement actually comes from, what a typical panel looks like in each setting, and how the medical review officer process fits in.
Is physician drug testing required by federal law
No general federal law requires routine drug testing of physicians. Federal testing mandates under 49 CFR Part 40 and the companion rule at 49 CFR Part 382 apply to safety sensitive transportation roles, mainly commercial drivers regulated by the Federal Motor Carrier Safety Administration. A physician only falls under that framework if the role itself requires a commercial driver license, which is not a normal part of clinical practice. Outside that narrow transportation context, whether and how a physician gets tested is set by the employer's own policy, the terms of a DEA controlled substance registration, or state licensing law, and state law varies, so a hospital in one state may run a different program than a hospital in another.
Where the actual requirement comes from
Four separate triggers explain almost every physician drug test that happens outside a courtroom or a traffic stop.
Hospital and group credentialing is the most common. Most hospitals and health systems require a pre employment or privileging drug screen as a condition of medical staff membership, written into the organization's own bylaws and employment policy rather than into any statute. Because this is private employer policy, the panel, the cutoff levels, and the consequences of a positive result are set by the hospital, not by a government agency.
For cause or reasonable suspicion testing follows the same logic. If a colleague, supervisor, or patient safety event raises a specific, documented concern about impairment, most hospital policies allow an immediate test. Hospitals that also use post incident testing after a clinical error or needlestick should be aware of the anti retaliation limits on blanket post incident testing described at 29 CFR 1904.35, which require that a testing policy not be designed or applied in a way that discourages legitimate injury reporting.
DEA registration is a third trigger, and it is specific to prescribing physicians. Every physician who prescribes controlled substances holds a registration under the rules at 21 CFR Part 1306, and the DEA's Diversion Control Division is the agency that investigates suspected drug diversion by registrants, including physicians suspected of self prescribing, altering records, or diverting supply from a hospital's own stock. A diversion investigation can lead to testing requirements imposed through a settlement, a state board order, or a hospital's own corrective action, but the DEA itself does not run a routine employee testing program.
State medical board action and Physician Health Program referral is the fourth and often the longest running trigger, covered in more detail below.
State medical boards and Physician Health Programs
Every state medical board has authority to investigate a licensee for impairment and to condition continued licensure on monitoring, and most states operate or recognize a Physician Health Program, usually called a PHP, that manages that monitoring. A verified example is Virginia's Health Practitioners Monitoring Program, run through the Virginia Department of Health Professions, which accepts referrals from licensing boards, employers, and self referrals, and which places a physician under a written monitoring agreement that typically includes random testing over a period of years. The program's own description of participation and testing expectations is posted on its program overview page.
State law and board procedure vary considerably, so a physician licensed in one state should not assume another state's PHP rules, agreement length, or test menu apply to their own board. What is consistent across most programs is the basic structure: a multi year written agreement, random and unannounced testing rather than a fixed schedule, a defined list of consequences for a missed or positive test, and confidentiality protections for treatment records that track the federal confidentiality rule for substance use disorder records at 42 CFR Part 2. A physician referred to a PHP, whether by self report, a colleague, or a board complaint, should get the specific agreement terms in writing and ask the program directly which analytes its testing panel covers, since that list is set by the program and not standardized nationally.
Typical panels by setting
Panel design changes depending on who is requiring the test and why. The table below describes typical configurations, not a promise of what any specific hospital or board will use.
| Setting or trigger | Who requires it | Typical panel or test | Notes |
|---|---|---|---|
| Hospital or group credentialing, pre employment | Employer or medical staff bylaws | Standard 10 or 12 panel urine or oral fluid screen | Set by employer policy, not federal law |
| For cause or reasonable suspicion | Employer policy following a documented concern | Expanded opioid panel plus fentanyl, lab confirmation | Fentanyl is commonly added because standard opiate strips do not reliably catch it |
| DEA diversion concern involving anesthesia or controlled drugs | DEA action, hospital corrective action, or board order | Send out laboratory LC/MS or GC/MS panel, may target propofol specifically | Propofol is not detected by rapid immunoassay cups or dip cards and requires a laboratory test built to look for it |
| State medical board referral or Physician Health Program monitoring | State medical board or PHP agreement | Random unannounced testing, often including ethyl glucuronide, PEth, and an expanded drug panel | Agreement length and analyte list vary by state and by program |
| Commercial driver duties, rare outside clinical practice | Federal DOT rule | DOT five panel urine test under 49 CFR Part 40 | Applies only if the role itself requires a commercial driver license |
The propofol point is worth repeating on its own, because it is a common source of confusion. Propofol is an intravenous anesthetic with high diversion risk among anesthesia staff, but it does not metabolize into a compound that a standard immunoassay strip is built to catch. Any program concerned about propofol diversion has to send a specimen to a laboratory running a method built specifically to detect it, not a rapid cup or card.
The medical review officer and documentation
Any positive screening result in a credentialing, for cause, or monitoring program should go through a medical review officer, a licensed physician trained to review laboratory results before they are reported to the hospital, the employer, or the board. The MRO's job is to verify whether a legitimate prescription or medical explanation accounts for the result before anything is reported as a verified positive, and SAMHSA maintains federal workplace drug testing program resources, including MRO training materials, that both federal and many non federal programs are built around. Our detailed walkthrough of that process is in the medical review officer process explained for employers.
A physician being tested under any of these programs should document current prescriptions and any recent legitimate exposure, such as a prescribed controlled substance for a physician's own medical condition, at the time of collection, not after a result comes back. That documentation is what allows an MRO to resolve a result without it ever reaching the employer or board as an unexplained positive. None of this is dosing or treatment advice, and a physician with a specific medication or health question should raise it with their own treating provider, not rely on a program's testing policy to answer it.
Building or reviewing a program
A hospital, medical group, or PHP vendor setting up or revisiting a testing program should match the panel to the actual risk, which for physicians usually means an expanded opioid panel with fentanyl coverage for credentialing and for cause testing, plus a plan to route anesthesia adjacent concerns like propofol to a laboratory rather than a rapid device. SAMHSA's employer resources page is a useful starting point for program design language, alongside the DEA's own publications on registrant accountability for anyone building the diversion prevention side of a program. Our related article on hospital employee drug testing panels, policies, and diversion goes deeper into panel and policy design for an entire hospital staff, not just physicians.
Hospitals, practice groups, and PHP administrators buying cups, dip cards, oral fluid devices, or lab referral supplies in volume can review current panel configurations through the wholesale portal at wholesale.americanscreeningcorp.com, or browse individual configurations in the drug test cup collection.
Frequently asked questions
Does federal law require physicians to be drug tested
No general federal law requires it. Federal testing rules under 49 CFR Part 40 apply mainly to safety sensitive transportation roles, which is not a normal part of clinical practice. Testing requirements for physicians usually come from employer policy, DEA registration accountability, or state medical board and PHP rules instead.
What triggers a physician drug test
The most common triggers are hospital or group credentialing at hire, for cause testing after a documented concern, a DEA diversion investigation tied to a controlled substance registration, and state medical board referral into a Physician Health Program after a complaint or self report.
Does a standard hospital panel detect propofol
No. Propofol is not detected by rapid immunoassay cups or dip cards. A program concerned about propofol diversion has to send a specimen to a laboratory running a method built specifically to look for it.
What is a Physician Health Program
A Physician Health Program, usually called a PHP, is a state connected monitoring program that manages a licensee's treatment and testing agreement, often under a multi year written contract with random unannounced testing. Program structure and state law vary, and Virginia's Health Practitioners Monitoring Program is one verified public example.
Who reviews a physician's positive test result
A medical review officer, a licensed physician trained to review laboratory results, verifies whether a legitimate prescription or medical explanation accounts for a result before it is reported to an employer or board as a verified positive.
Can a physician be fired or disciplined for a positive drug test
Outcomes depend on the employer's policy, the medical staff bylaws, and the state medical board's own rules, so a physician facing this situation should review the specific program agreement and may want to consult counsel rather than assume a single outcome applies everywhere.
This article is general information about physician drug testing programs, not legal or medical advice. Decisions about a specific credentialing policy, DEA matter, or Physician Health Program agreement should involve qualified counsel, the relevant state medical board, or a medical review officer.
